A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This 3 arm, placebo-controlled study will investigate the effect of Taspoglutide on gastric
emptying in patients with type 2 diabetes. Patients will be randomized into one of 3 groups
to receive a)10mg Taspoglutide sc weekly for 12 weeks b)10mg Taspoglutide sc weekly for 4
weeks followed by 20mg Taspoglutide sc weekly for 8 weeks or c) placebo sc weekly for 12
weeks, with all injections administered in the abdomen.Gastric emptying will be assessed by a
paracetamol test at intervals during the study. The anticipated time on study treatment is 3
months, and the target sample size is <100 individuals.